ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2024; 15(16):5132-5133. doi:10.7150/jca.99135 This issue Cite
Erratum
TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: Erratum
Weiwei Liu*, Qian Feng*, Wenjun Liao*, Enliang Li 
, Linquan Wu
Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Nanchang University, 1 Mindle Road, Nanchang Jiangxi 330006, P.R. China.
*These authors contributed equally to this work.
Citation:
Liu W, Feng Q, Liao W, Li E, Wu L. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: Erratum. J Cancer 2024; 15(16):5132-5133. doi:10.7150/jca.99135. https://www.jcancer.org/v15p5132.htm
Other stylesCorrected-article in J Cancer, Volume 12, 6905
In our published paper, due to the error in editing images, Figure 6D,7F,9E appeared to have incorrect use of pictures, and we provide the updated pictures below. At the same time, since the Figure legend in Figure 5 is not accurate enough, we also correct it. We deeply regret and sincerely apologize for these errors and any inconvenience that may have been caused to the readers and editors of this journal.
Figure 5 correct legend: The relationship between miR-29a and IFITM3 A. Immunofluorescence analysis of IFITM3 expression in HCC-LM3 and HL-7702 at a scale of 200 mm. B. qRT-PCR was used to detect the expression of miR-29a and IFITM3 in HCC. C. The prognosis of patients with high expression of IFITM3 is worse than that of patients with low expression of IFITM3. D. Changes in IFITM3 mRNA levels after miR-29a inhibitor and IFITM3 siRNA transfection. E. Changes in IFITM3 protein levels after miR-29a inhibitor and IFITM3 siRNA transfection. F. The Targetscan website is used to predict the relationship between miR-29a and IFITM3.
Figure A
Correct images for figures 6D,7F,9E. 6D. changes in apoptosis rate of cells transfected with miR-29a inhibitor and IFITM3 siRNA. 7F. changes in apoptosis rate of cells transfected with si-TUG1 and IFITM3 vectors. 9E. Lung metastasis-related detection. H&E staining of lung tissue for histological analysis.
Author contact
Corresponding authors: Mr. Enliang Li or Professor Linquan Wu, E-mail: lienliangyxcom; E-mail: wulqnccom.
Published 2024-8-8
Citation styles
APA
Liu, W., Feng, Q., Liao, W., Li, E., Wu, L. (2024). TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: Erratum. Journal of Cancer, 15(16), 5132-5133. https://doi.org/10.7150/jca.99135.
ACS
Liu, W.; Feng, Q.; Liao, W.; Li, E.; Wu, L. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: Erratum. J. Cancer 2024, 15 (16), 5132-5133. DOI: 10.7150/jca.99135.
NLM
Liu W, Feng Q, Liao W, Li E, Wu L. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: Erratum. J Cancer 2024; 15(16):5132-5133. doi:10.7150/jca.99135. https://www.jcancer.org/v15p5132.htm
CSE
Liu W, Feng Q, Liao W, Li E, Wu L. 2024. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a: Erratum. J Cancer. 15(16):5132-5133.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.